What is the recommended treatment for keratoconjunctivitis?

Treatment of Keratoconjunctivitis

Treatment for keratoconjunctivitis is type-specific and requires identifying the underlying etiology, with management ranging from simple lubricants for mild superior limbic keratoconjunctivitis to immediate contact lens discontinuation for contact lens-related disease, systemic tetracyclines for rosacea-associated disease, and topical immunomodulators for allergic forms 1.

Treatment Algorithm by Type

Superior Limbic Keratoconjunctivitis (SLK)

Mild cases:

• Start with lubricants, mast-cell stabilizers, and topical cyclosporine 1
• Consider soft contact lenses or punctal occlusion for symptomatic relief
• For associated filamentary keratitis: topical 10% acetylcysteine or hypertonic 5% saline 1

Persistent/severe cases:

• Surgical intervention: chemical or thermal cautery to tighten redundant conjunctiva, or conjunctival resection 1

Critical caveat: Up to 65% of SLK patients have underlying thyroid dysfunction—always screen with thyroid antibody tests 1. However, treating the thyroid disease does not improve the SLK itself. Counsel patients that this is a chronic, recurrent condition that rarely decreases vision but requires symptom-driven follow-up over years 1.

Rosacea Conjunctivitis

Comprehensive approach includes:

• Eyelid hygiene and warm compresses (foundational)
• Systemic tetracyclines (primary pharmacologic treatment)
• Topical corticosteroids and cyclosporine for inflammation
• Topical metronidazole creams/ointment
• Advanced options: mechanical thermal pulsations, intense pulsed light therapy 1

Contact Lens-Related Keratoconjunctivitis

Immediate action:

• Discontinue contact lens wear immediately until cornea returns to normal 1—this is non-negotiable as the condition results from limbal stem cell hypoxia causing punctate epithelial keratitis, pannus, neovascularization, and potentially permanent epitheliopathy

Pharmacologic treatment for mild cases:

• Brief 1-2 week course of topical corticosteroids
• Longer-term topical cyclosporine 0.05% 1

Critical warning: If moderate or severe pain is present, rule out amoebic keratitis 1

Follow-up management:

• Review contact lens fit, type, and care regimen
• Switch to nonpreserved lens care systems, daily disposable lenses, or high DK/T ratio materials
• Reduce wearing time
• Consider alternatives (eyeglasses or refractive surgery) once resolved 1

Giant Papillary Conjunctivitis (GPC)

Primary strategy: modify the causative entity

• Remove/replace protruding suture knots or rotate them
• Clean, polish, or replace ocular prostheses
• For contact lens-related GPC:
  • Replace lenses more frequently
  • Decrease wearing time
  • Use preservative-free lens care systems
  • Administer mast-cell stabilizing agents
  • Refit or switch to daily disposable lenses
  • Change contact lens polymer 1

Treat associated conditions: aqueous tear deficiency and meibomian gland dysfunction 1

For active inflammation: Discontinue contact lens use with topical anti-inflammatory agents 1

Vernal and Atopic Keratoconjunctivitis

Stepwise approach based on severity:

Mild to moderate:

• Mast cell stabilizers and antihistamines 2, 3
• Topical cyclosporine 0.1% cationic emulsion is highly effective with high patient satisfaction 4

Severe cases:

• Topical corticosteroids as rescue medication for acute exacerbations 2
• Topical cyclosporine A for long-term management (proven effective without significant side effects) 2
• Combination therapy: Recent evidence shows topical tacrolimus 0.1% ointment combined with prednisolone 1% drops provides faster recovery than tacrolimus alone 5

Critical monitoring: When using corticosteroids, perform baseline and periodic IOP measurement and pupillary dilation to evaluate for glaucoma and cataract 1. Four patients in one study developed elevated IOP after three months of combination therapy 5.

Important note: Vernal and atopic keratoconjunctivitis must be controlled prior to corneal cross-linking to decrease the risk of developing sterile keratitis 1

Epidemic Keratoconjunctivitis (EKC) with Subepithelial Infiltrates

For nummular keratitis/subepithelial infiltrates:

• Avoid early corticosteroid treatment at initial diagnosis—this is associated with chronic persistence 6
• Optimal approach: Delayed initiation (6 weeks after diagnosis) of combination treatment with corticosteroids and cyclosporine—this demonstrates the highest long-term effectiveness and leads to complete resolution after 1 year 6
• Monotherapy with cyclosporine alone shows lower efficacy 6
• Alternative: Topical tacrolimus 0.1% ointment alone or combined with prednisolone 1% drops is effective, with combination therapy providing faster recovery 5

General Monitoring Principles

For all patients on corticosteroids:

• Baseline IOP and pupillary dilation
• Periodic monitoring for glaucoma and cataract development 1

Follow-up frequency: Based on disease severity and treatment used, including interval history, visual acuity measurement, and slit-lamp biomicroscopy 1